Larry Goldenberg is a dedicated surgeon and visionary leader who co-founded the Prostate Centre at VGH, the largest and most comprehensive prostate-specific research and treatment facility in Canada. An internationally renowned clinician and researcher, he was a pioneer in the use of intermittent hormone withdrawal, which is now considered a standard treatment option. He also developed a low dose antiandrogen/DES protocol that was the principal therapy used in BC for advanced prostate cancer until the mid-90's. His work has led to numerous clinical trials, with the promise of bringing innovative treatment alternatives to men with prostate cancer.